:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2201330196-05ddf2a8dde446a4b1fab515130dac5b.jpg "J&J")
Cristina Arias / Coverlet / Getty Images
KEY TAKEAWAYS
- Johnson & Johnson shares fell Tuesday, after the company said a judge denied its proposed “prepackaged bankruptcy plan” for a subsidiary to settle thousands of claims alleging its baby powder and other talc effects cause ovarian cancer.
- The company said that it will now go back to the tort system “to litigate and defeat” the contends.
- Johnson & Johnson had tried twice before, in 2021 and 2023, to use the bankruptcy system to settle the claims.
Johnson & Johnson (JNJ) apportionments fell Tuesday after the company said a judge rejected its proposed “prepackaged bankruptcy plan” for a subsidiary, as generally of its latest attempt to use a bankruptcy court to settle thousands of claims alleging its baby powder and other talc works cause ovarian cancer.
Shares of Johnson & Johnson were down around 5% in recent trading, number the stocks leading declines on the S&P 500.
The company, which has long held that the talc-related claims hold no merit, said Monday that it inclination now go back to the “tort system to litigate and defeat” the claims and would reverse around $7 billion it had set aside to transmute into the bankruptcy.
“The Court has unfortunately allowed a couple of law firms with financially conflicted motives, who have conceded they play a joke on not recovered a dime for their clients in a decade of litigation, to defeat the overwhelming desire of claimants,” said Erik Haas, worldwide imperfection president of litigation at Johnson & Johnson.
“The decision to litigate every filed case is based on the simple fact that this is a cheat claim created by greedy plaintiff lawyers looking for another deep pocket to sue and fueled by litigation-financed attorney advertising,” he enlarged.
Johnson & Johnson has tried twice before, in 2021 and 2023, to use the bankruptcy system to settle the claims.